SCHEMBL29904643

SCHEMBL29904643

CN1CCN(C2CCN(c3ncc(Nc4ncc(Cl)c(N(c5ccc6scnc6c5NS(C)(=O)=O)S(C)(=O)=O)n4)cc3F)CC2)CC1

nearest known ligand 0.42

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
▸ EGFR P00533 12/20 0.42
▸ MET P08581 1/20 0.39
▸ ALK Q9UM73 5/20 0.37
▸ INSR P06213 4/20 0.37
▸ IGF1R P08069 4/20 0.37
▸ AXL P30530 1/20 0.37
▸ FGFR3 P22607 1/20 0.36
▸ KCNH2 Q12809 1/20 0.36
▸ CCNT1 O60563 1/20 0.35
▸ CDK4 P11802 1/20 0.35
▸ CCND1 P24385 1/20 0.35
▸ CDK9 P50750 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26906780 1.00 EGFR (0.42) EGFRMETALKINSRIGF1R
SCHEMBL26906903 0.92 EGFR (0.44) EGFRKCNH2CCNT1CDK4CCND1
SCHEMBL29114858 0.91 EGFR (0.43) EGFRMETALKINSRIGF1R
SCHEMBL26906899 0.84 EGFR (0.49) EGFRMETALKINSRIGF1R
SCHEMBL26907013 0.83 ALK (0.52) EGFRMETALKINSRIGF1R
SCHEMBL26906727 0.83 ALK (0.50) EGFRMETALKINSRIGF1R
SCHEMBL29904674 0.83 ALK (0.50) EGFRMETALKINSRIGF1R
SCHEMBL29114849 0.75 EGFR (0.51) EGFRMETALKINSRIGF1R
SCHEMBL29114867 0.74 ALK (0.53) EGFRMETALKINSRIGF1R
SCHEMBL29904646 0.74 EGFR (0.62) EGFRMETALKINSRIGF1R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022211573-A1 PYRIMIDINE DERIVATIVE HAVING PROTEIN KINASE INHIBITORY ACTIVITY, AND THERAPEUTIC PHARMACEUTICAL COMPOSITION COMPRISING SAME 주식회사 테라펙스 2022-10-06 — — WO claimed
WO-2022211573-A1 PYRIMIDINE DERIVATIVE HAVING PROTEIN KINASE INHIBITORY ACTIVITY, AND THERAPEUTIC PHARMACEUTICAL COMPOSITION COMPRISING SAME 주식회사 테라펙스 2022-10-06 — — WO disclosed
Send feedback